Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
"Tight control of proteinuria in newly diagnosed lupus nephritis The last 3 years have been exciting times in the field of lupus nephritis (LN) with two new licensed therapies, belimumab (BAFF-inhibitor) and voclosporin (calcineurin-inhibitor). https://t.co/Q7TahfZiB0" (,@RheumNow) Dec 9, 2022 
Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease
https://twitter.com/RheumNow/status/1601351036215742466
 
Dec 9, 2022
 
 
7c3df6ec-2fcf-48ea-9db8-050d498cb202.jpg